Covidien boosts endoscopy offering with New Wave, while recall hits sales
This article was originally published in Clinica
Executive Summary
Covidien has reportedly paid $100m to acquire New Wave Surgical, a developer of laparoendoscopic surgical devices. The deal was announced on New Wave’s website on 28 March but was only widely reported last week, with the $100m fee unconfirmed but cited by several news outlets. Pompano Beach, Florida-based New Wave has developed a device called D-Help that keeps laparoscopic lenses clean and “defogged” during surgery. The product received US FDA 510(k) clearance in 2006, and was used in its millionth procedure in February. D-Help will be sold by Covidien as the Clearify visualization system – but apart from that, New Wave says existing customers will see little impact. But Covidien’s marketing reach should boost uptake of the device.
You may also be interested in...
What are the hottest innovations from Israel?
Israel is well-known as a medtech hot-spot, with a focus on academic research and strong government support helping the country punch well above its weight when it comes to innovative devices.
EuroPCR: St Jude and Philips talk up rival intravascular imaging techs
St Jude Medical had a heavy focus on its intravascular imaging offering at this year’s EuroPCR meeting, presenting data supporting its optical coherence tomography (OCT) technology. OCT provides intravascular images to help assess culprit lesions, which can improve stent selection and deployment, according to St Jude.
EuroPCR: Medtronic's drug-coated balloon keeps rising
A big topic at this year’s EuroPCR, held in Paris on 19-22 May, was drug-coated balloons (DCBs). One of the leaders in the field, Medtronic, presented positive data from two studies of its IN.PACT Admiral balloon, which could support an expanded indication for the device.